Concepedia

Volker Wacheck

VW

70

Publications

4.7K

Citations

37

H-Index

2000

Active since

Affiliations

Medical University of Vienna(Current)

University of Vienna

Eli Lilly (United States)

Vienna General Hospital

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA

Volker Wacheck is an author at Medical University of Vienna specializing in medicine, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2000–2024

70

Publications

70

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

Burkhard Jansen, Volker Wacheck, Elisabeth Heere‐Ress et al. · The Lancet · 2000 · 481 citations

, , +6

Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma

Lipika Goyal, Funda Meric‐Bernstam, Antoine Hollebecque et al. · New England Journal of Medicine · 2023 · 465 citations · Full text

Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy

Wolfgang Sieghart, Doris Losert, Sabine Strommer et al. · Journal of Hepatology · 2005 · 251 citations · Full text

, , +8

Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides

Karl J. Aichberger, Matthias Mayerhofer, Maria‐Theresa Krauth et al. · Blood · 2004 · 251 citations · Full text

Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells

Edgar Selzer, Emilio Pimentel, Volker Wacheck et al. · Journal of Investigative Dermatology · 2000 · 174 citations · Full text

, , +10

Rows per page

1–5 of 70